Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Pre-Cold Medicine Products
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Class-Action Tracker
Zicam Products
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Zicam Pre-Cold Remedies
The Latest
What You Should Know about Telehealth Companies Selling Compounded Drugs
Ads don’t always give the full picture.
The Marketing Myth of the ‘Made in USA’ Car
TINA.org investigations expose the truth and prompt marketing changes
Best Buy’s ‘Laptop Discounts For Students’
You don’t need to be a student to get these discounted prices.
Toddler Formulas
These marketing claims have experts throwing a tantrum.
Why You Might be Trapped In That Gym Membership Forever
Some members of Congress want to kill a popular “click-to-cancel” rule.